Home Life Sciences Determination of 10B in lymphoma human cells after boron carrier treatment: comparison of 10BPA and immuno-nanoparticles
Article
Licensed
Unlicensed Requires Authentication

Determination of 10B in lymphoma human cells after boron carrier treatment: comparison of 10BPA and immuno-nanoparticles

  • Marco Persico EMAIL logo , Patrizia Chiari , Raffaela Biesuz and Giancarla Alberti
Published/Copyright: October 30, 2013
Become an author with De Gruyter Brill

Abstract

Current cancer treatments lead to insufficient distribution of therapeutic agents in tumor cells due to their lack of selectivity often causing adverse effects in the normal cell uptake of the drug. The challenge is to design therapeutic drugs able to maximize the treatment of malignant cancers while minimizing their adverse effects. In this study, 10B incorporation in the B chronic lymphocytic leukemia cell line MEC-1 was investigated. The cells were treated with l-p-10borophenylalanine (10BPA) and 10boron immuno-nanoparticles (BNPs) loaded with 10BPA with or without the anti-CD20 monoclonal antibody for different contact times. The uptake of 10B by the cells was determined by the inductively coupled plasma mass spectrometry (ICP-MS) after acid mineralization. To obtain accurate and consistent data, the analytical procedure was optimized using factorial experimental design. It was observed that BNP loaded with 10BPA and anti-CD20 represents the best carrier system for 10B in B cells for long time (>10 h) whereas 10BPA seems to be the top drug for short time (< 4 h) procedures.

[1] Arias, J. L., Reddy, L. H., & Couvreur, P. (2009). Polymeric nanoparticulate system augmented the anticancer therapeutic efficacy of gemcitabine. Journal of Drug Target, 17, 586–598. DOI: 10.1080/10611860903105739. http://dx.doi.org/10.1080/1061186090310573910.1080/10611860903105739Search in Google Scholar

[2] Barth, R. F., Coderre, J. A., Vicente, M. G. H., & Blue, T. E. (2005). Boron neutron capture therapy of cancer: Current status and future prospects. Clinical Cancer Research, 11, 3987–4002. DOI: 10.1158/1078-0432.ccr-05-0035. http://dx.doi.org/10.1158/1078-0432.CCR-05-003510.1158/1078-0432.CCR-05-0035Search in Google Scholar

[3] Bevilacqua, R., Giannini, G., Calligaris, F., Fontanarosa, D., Longo, F., Scian, G., Totaro, P., Vittor, K., Vallazza, E., Severgnini, M., Vidimari, R., Barthesaghi, G., Conti, V., Mascagna, V., Perboni, C., Prest, M., Gambarini, G., Gay, S., Valente, M. A., Mozzanica, A., Monti, A., Ostinelli, A., Azario, L., Fidanzio, A., Piermattei, A., Borla, O., Durisi, E., Fasolo, F., Nastasi, U., Perosino, E., Zanini, A., & Tommasino, L. (2007). PhoNeS:A novel approach to BNCT with conventional radiotherapy accelerators. Nuclear Instruments and Methods in Physics Research A, Accelerators, Spectrometers, Detectors and Associated Equipment, 572, 231–232. DOI: 10.1016/j.nima.2006.10.290. http://dx.doi.org/10.1016/j.nima.2006.10.29010.1016/j.nima.2006.10.290Search in Google Scholar

[4] Evans, S., & Krähenbühl, U. (1994). Improved boron determination in biological-material by inductively-coupled plasmamass spectrometry. Journal of Analytical Atomic Spectrometry, 9, 1249–1253. DOI: 10.1039/ja9940901249. http://dx.doi.org/10.1039/ja994090124910.1039/JA9940901249Search in Google Scholar

[5] Goodwin, J. T., Farr, L. E., Sweet, W. H., & Robertson, J. S. (1955). Pathological study of eight patients with glioblastoma multiforme treated by neutron-capture therapy using boron 10. Cancer, 8, 601–615. DOI: 10.1002/1097-0142(1955)8:3〈601::aid-cncr2820080326〉3.0.co;2-r. http://dx.doi.org/10.1002/1097-0142(1955)8:3<601::AID-CNCR2820080326>3.0.CO;2-R10.1002/1097-0142(1955)8:3<601::AID-CNCR2820080326>3.0.CO;2-RSearch in Google Scholar

[6] Leardi, R. (2009). Experimental design in chemistry: A tutorial. Analytica Chimica Acta, 652, 161–172. DOI: 10.1016/j.aca.2009.06.015. http://dx.doi.org/10.1016/j.aca.2009.06.01510.1016/j.aca.2009.06.015Search in Google Scholar

[7] Luo, G. P., Yu, X. J., Jin, C., Yang, F., Fu, D. L., Long, J., Xu, J., Zhan, C. G., & Lu, W. Y. (2010). LyP-1-conjugated nanoparticles for targeting drug delivery to lymphatic metastatic tumours. Internationa Journal of Pharmaceutics, 385, 150–156. DOI: 10.1016/j.ijpharm.2009.10.014. http://dx.doi.org/10.1016/j.ijpharm.2009.10.01410.1016/j.ijpharm.2009.10.014Search in Google Scholar

[8] Marin, G. H., Mansilla, E., Mezzaroba, N., Zorzet, S., Nunez, L., Larsen, G., Tau, J. M., Maceira, A., Spretz, R., Mertz, C., Ingrao, S., Tripodo, C., Tedesco, F., & Macor, P. (2010). Exploratory study on the effects of biodegradable nanoparticles with drugs on malignant B cells and on a human/mouse model of Burkitt lymphoma. Current Clinical Pharmacology, 5, 246–250. DOI: 10.2174/157488410793352058. http://dx.doi.org/10.2174/15748841079335205810.2174/157488410793352058Search in Google Scholar

[9] Pandolfi, L., Giannini, G., Macor, P., Mezzaroba, N., Pozzato, G., & Vidimari, R. (2013). i-BNCT: immuno-BNCT with immuno-nanoparticle boron carriers. Applied Radiation and Isotopes. (accepted) Search in Google Scholar

[10] Rao, D. A., Forrest, M. L., Alani, A. W. G., Kwon, G. S., & Robinson, J. R. (2010). Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery. Journal of Pharmaceutical Science, 99, 2018–2031. DOI: 10.1002/jps.21970. 10.1002/jps.21970Search in Google Scholar

[11] Sah, R. N., & Brown, P. H. (1997). Boron determination-a review of analytical methods. Microchemical Journal, 56, 285–304. DOI: 10.1006/mchj.1997.1428. http://dx.doi.org/10.1006/mchj.1997.142810.1006/mchj.1997.1428Search in Google Scholar

Published Online: 2013-10-30
Published in Print: 2014-2-1

© 2013 Institute of Chemistry, Slovak Academy of Sciences

Articles in the same Issue

  1. Synthesis and characterisation of a novel bi-nuclear copper2+ complex and its application as electrode-modifying agent for simultaneous voltammetric determination of dopamine and ascorbic acid
  2. Synthesis of ethyl-6-aminohexanoate from caprolactam and ethanol in near-critical water
  3. Vanadium dodecylamino phosphate: A novel efficient catalyst for synthesis of polyhydroquinolines
  4. Modelling and experimental validation of enantioseparation of racemic phenylalanine via a hollow fibre-supported liquid membrane
  5. Influence of operating conditions on performance of ceramic membrane used for water treatment
  6. Mercury associated with size-fractionated urban particulate matter: three years of sampling in Prague, Czech Republic
  7. Chemical composition and antioxidant activity of sulphated polysaccharides extracted from Fucus vesiculosus using different hydrothermal processes
  8. A new organically templated magnesium sulfate: structure, spectroscopic analysis, and thermal behaviour
  9. Synthesis, characterization and photoluminescence properties of Ce3+-doped ZnO-nanophosphors
  10. Synthesis and photophysical properties of new Ln(III) (Ln = Eu(III), Gd(III), or Tb(III)) complexes of 1-amidino-O-methylurea
  11. Polycarbonate-based polyurethane elastomers: temperature-dependence of tensile properties
  12. Synthesis of a disulfide functionalized diacetylenic derivative of carbazole as building-block of polymerizable self-assembled monolayers
  13. Properties of poly(lactic acid-co-glycolic acid) film modified by blending with polyurethane
  14. Determination of 10B in lymphoma human cells after boron carrier treatment: comparison of 10BPA and immuno-nanoparticles
  15. Molecular modelling and spectral investigation of some triphenyltetrazolium chloride derivatives
  16. X-ray molecular structure and theoretical study of 1,4-bis[2-cyano-2-(o-pyridyl)ethenyl]benzene
  17. 1,3-Dipolar cycloaddition between substituted phenyl azide and 2,3-dihydrofuran
Downloaded on 21.12.2025 from https://www.degruyterbrill.com/document/doi/10.2478/s11696-013-0435-4/html
Scroll to top button